Navigation Links
Abaxis Reports Financial Performance For The First Quarter Of Fiscal 2014
Date:7/25/2013

cilities or manufacturing operations, fluctuations in quarterly operating results, dependence on sole suppliers, the market acceptance of Abaxis' products and services, the continuing development of its products, required United States Food and Drug Administration clearance and other government approvals, risks associated with manufacturing and distributing its products on a commercial scale free of defects, risks related to the introduction of new instruments manufactured by third parties, risks associated with competing in the human diagnostic market, risks related to the protection of Abaxis' intellectual property or claims of infringement of intellectual property asserted by third parties and risks related to condition of the United States economy.  Readers should also refer to the section entitled "Risk Factors" in Abaxis' annual report on Form 10-K, recent quarterly reports on Form 10-Q and Abaxis' other periodic reports filed with the United States Securities and Exchange Commission.  Forward-looking statements speak only as of the date the statements were made.  Abaxis does not undertake and specifically disclaims any obligation to update any forward-looking statements.

Financial Tables to FollowABAXIS, INC.Condensed Consolidated Statements of Income(In thousands, except per share data)(Unaudited)Three Months EndedJune 30,20132012Revenues

$
43,169

$
42,014Cost of revenues

22,277

19,165Gross profit

20,892

22,849Operating expenses:Research and development 

3,173

2,965Sales and marketing 

10,028

11,769General and administrative

3,055

3,322Total operating expenses

16,256

18,056Income from operations

4,636

4,793Interest and other income (expense), net

404

(230)Income before income tax provision

5,040

4,563Income tax provision

1,811


'/>"/>
SOURCE Abaxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Abaxis, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
2. Abaxis Enters Into Definitive Agreement To Deliver 300 Piccolo Xpress Instruments For A Four-Year Drug Clinical Trial
3. Abaxis To Report First Quarter Fiscal Year 2013 Financial Results Thursday, July 26, 2012
4. Abaxis Reports Financial Performance For The First Quarter Of Fiscal 2013
5. Abaxis, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
6. Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference
7. Abaxis, Inc. to Present at CL Kings 10th Annual Best Ideas Conference 2012
8. Abaxis, Inc. to Present at UBS Global Life Sciences Conference
9. Abaxis Announces the Launch of Kidney Profile Plus Panel
10. Abaxis Announces Exclusive Distribution Agreement with Abbott
11. Abaxis, Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 31, 2015 Quietly, sedately, Morocco,s ... the domestic pharmaceutical industry is strong, with a well-developed ... high international standards. One place where the ... sub-Saharan Africa: Morocco has quietly become the second largest ... Africa . Indeed, Moroccan pharma companies have been ...
(Date:7/31/2015)... , July 31, 2015 ... Analyzers Market by Product (Bioimpedance Analyzers (BIA), Dual-Energy X-ray ... Hydrostatic Weighing) - Global Analysis & Forecast to 2019", ... was pegged at $911.1 Million 2014 and is estimated ... a CAGR of 9.4% from 2014 to 2019. ...
(Date:7/30/2015)... , July 30, 2015 IRIDEX Corporation ... release its second quarter 2015 financial results after the ... In conjunction with the release, the Company will host ... 5:00 p.m. Eastern Time on Thursday, August ... quarter and other business developments. Interested parties ...
Breaking Medicine Technology:PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2
... May 25, 2012  ... and Multilab Indústria e Comércio de Produtos Farmacêuticos ... jointly announced that both parties have signed an ... Brazil, "Takeda Brazil"), a wholly-owned subsidiary of Takeda, ...
... 2012  The National Organization for Rare Disorders (NORD) applauds legislation ... the Food and Drug Administration Safety & Innovation Act ... the most comprehensive improvements to public policy for rare disease ... . (Logo: http://photos.prnewswire.com/prnh/20110719/DC37656LOGO-b ) ...
Cached Medicine Technology:Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil 2Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil 3Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil 4NORD Calls Senate Bill Most Important Since Orphan Drug Act 2
(Date:7/31/2015)... ... July 31, 2015 , ... Precision Aesthetics is New York’s only Thermage ... also the first provider of Exilis non-surgical fat reduction in New York. Due ... attracted a large International clientele. Many patients travel to New York to get ...
(Date:7/31/2015)... ... July 31, 2015 , ... The 2nd annual Ride to Fight On ... on October 3, 2015. The Ride to Fight On is a cycling fundraiser that ... Healthcare, The West Clinic and The University of Tennessee Health Science Center. A health ...
(Date:7/31/2015)... ... 31, 2015 , ... Jacksonville-based drug and alcohol rehabilitation center, ... Center. The medical community, social workers, law enforcement, and government officials are all ... the effort to better understand and combat sex trafficking. Lead by sex trafficking ...
(Date:7/31/2015)... ... July 31, 2015 , ... M3 USA MDLinx.com, source of the ... new Board Exam Courses. , The additions of Gastroenterology, Pulmonology and Allergy/Immunology round ... MDLinx makes preparing for the exam easy and painless. MDLinx offers thousands of ...
(Date:7/31/2015)... ... July 31, 2015 , ... According to an ... gathered to see if they could reach a consensus on the steps that need ... facelifts. Overall, the group reached 90 percent consensus on a series of steps that ...
Breaking Medicine News(10 mins):Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3
... ... teach participants unique personal marketing strategies to find employment with a six-point system “The ... is a former talk show host in Columbia at WVOC 560 AM; Kenneth Shuler ... be held for Thomas providing free career counseling services , ...
... ... infection 33 times greater than that reported for our accredited ambulatory surgery centers. ... (PRWEB) June 18, ... Schaefer, Michael Jhung et al (JAMA 2010;303(22):2273 - 2279) correctly places emphasis on the ...
... disorder affecting one in 100 people worldwide. Most cases aren,t ... hallucinations as a teenager or adult. By that time, the ... difficult to treat. In a paper published recently online ... the University of North Carolina at Chapel Hill and Columbia ...
... The National Heart, Lung, and Blood Institute (NHLBI), part of ... to determine if the safety and efficacy of red blood ... been stored. One of the grants supports the first large, ... patients who receive transfusions of red blood cells that have ...
... ... to help women restore energy, passion and healthy hormonal balance. , ... Tampa, FL (Vocus) June 21, 2010 ... supplement for women. Dan-e™ is made of a patent-pending blend of Pro-Hormones and vital ...
... University of Leicester and the University of Ferrara in Italy ... to relieve cancer pain without causing many of the side ... show that 90% of cancer patients experience pain in the ... problem. Currently, the use of drugs like morphine produces side ...
Cached Medicine News:Health News:Columbia Extreme Job Makeover Slated for June 26 2Health News:Columbia Extreme Job Makeover Slated for June 26 3Health News:Infection Rate in Accredited Ambulatory Facilities is Lower than in Hospitals 2Health News:Brain signs of schizophrenia found in babies 2Health News:NHLBI funds research to improve safety of red blood cell transfusions 2Health News:NHLBI funds research to improve safety of red blood cell transfusions 3Health News:NHLBI funds research to improve safety of red blood cell transfusions 4Health News:NHLBI funds research to improve safety of red blood cell transfusions 5Health News:NHLBI funds research to improve safety of red blood cell transfusions 6Health News:NHLBI funds research to improve safety of red blood cell transfusions 7Health News:World Renowned Physician Launches Dan-e™ All-Natural Nutritional Supplement for Women 2Health News:New drugs to relieve cancer pain 2
... D15/810 diode laser is a versatile and ... soft tissue applications. With excellent hemostatic and ... flexible fiber optic delivery system that allows ... environments alike.,Compact and portable, the Ceralas D15/810 ...
... II is a monoclonal antibody based ... identification of Neisseria gonorrhoeae. The test ... run with no heating or pretreatment. ... viable or fresh cultures. GonoGen&trade II ...
The One-Step Gonorrhea Antigen Tests are qualitative immunoassays for detecting the Gonorrhea Antigen (NGH) in secretory products (swab)....
... thermal keratoplasty (LTK). This procedure was FDA ... reduction of hyperopia from +0.75 to +2.50 diopters ... to 0.75 diopters of astigmatism and refractive stability ... refractive surgery, LTK is not performed in an ...
Medicine Products: